|
2025
|
G/S
|
Pharmaceutical preparations and substances for the treatment
of autoimmune diseases and disorder... |
|
|
G/S
|
Pharmaceutical preparations and substances for the treatment of autoimmune diseases and disorders... |
|
|
Invention
|
Use of tyk2/jak1 inhibitors to treat amyloid-related imaging abnormalities (aria). Provided for a... |
|
|
Invention
|
Treatment of igg-related diseases. Provided is a method of treating a disease susceptible to a re... |
|
|
Invention
|
Activators of pyruvate kinase isoform m2 and methods for treating neurodegenerative disease. Prov... |
|
|
G/S
|
Pharmaceutical preparations and substances for the treatment of neurological, neuropsychiatric, n... |
|
|
G/S
|
Pharmaceutical preparations and substances for the treatment
of neurological, neuropsychiatric, ... |
|
|
Invention
|
Trpm3 antagonists for the treatment of migraine and pain. Described herein are methods of treatin... |
|
|
Invention
|
Treatment of alpha-synucleinopathies and neuroprotection. A method of treating an alpha-synuclein... |
|
|
Invention
|
Treatment of diseases with monoclonal antibody drugs and molecular degraders. A method of treatin... |
|
|
Invention
|
Combination therapy to treat overweight, obesity, and related health conditions. Provided herein ... |
|
|
Invention
|
Bifunctional degraders. A composition of matter including a binding moiety, a cellular receptor-b... |
|
|
Invention
|
Next generation riluzole prodrugs. 0-inf0-inf for riluzole of about 80% to about 125% of about 79... |
|
|
Invention
|
Bifunctional degraders of anti-pla2r antibody. A composition of matter including an anti-PLA2R an... |
|
|
Invention
|
Myostatin-binding proteins. Provided herein are polypeptides that bind myostatin with improved PK... |
|
|
Invention
|
Bifunctional degraders of igg4 immunoglobulins. A composition of matter including an IgG4-binding... |
|
|
Invention
|
Synthesis of phosphine ligands. tert11-5231-51-5 alkoxy; and Cy is cyclohexyl. |
|
2024
|
Invention
|
Combination treatment of neurological disorders. A method of treating a depressive disorder, or a... |
|
|
Invention
|
Ii auto-antibodies. The disclosure describes compounds of Formula (I) and Formula (II), which in ... |
|
|
Invention
|
Trpm3-modulating benzofuran derivatives. The invention relates to compounds that are useful for t... |
|
|
Invention
|
Trpm3-modulating indolizine derivatives. The invention relates to compounds that are useful for t... |
|
|
G/S
|
Pharmaceutical research, development, discovery, testing, and collaborative research for others, ... |
|
|
G/S
|
Pharmaceutical research, development, discovery, testing,
and collaborative research for others,... |
|
|
Invention
|
Combination treatment of autoimmune disorders. Provided is a method of treating rheumatoid arthri... |
|
|
Invention
|
Bispecific molecular degraders of pathogenic proteins. Provided are bispecific degraders of extra... |
|
|
G/S
|
Pharmaceutical research and development in the fields of headache, facial pain, impulse control d... |
|
|
Invention
|
M ethods of treating epilepsy and related disorders with potent and selective potassium channel a... |
|
|
Invention
|
Extended-release formulations of kv7.2/7.3 potassium channel activators. Described herein are sol... |
|
|
Invention
|
Process for producing (3s,6r)-6-(cyanomethyl)- tetrahydro-2h-pyran-3-amine. The present disclosur... |
|
|
Invention
|
Molecular degraders for the treatment of iga nephropathy. The present invention the invention con... |
|
|
Invention
|
Trpm3 modulators for treatment of pain. Disclosed are pharmaceutical compositions including a pha... |
|
|
Invention
|
Asgpr binders and compositions and methods thereof. The present disclosure relates to asiaglycopr... |
|
|
Invention
|
Bifunctional degraders of galactose-deficient immunoglobulins. A composition of matter including ... |
|
|
Invention
|
Antibody recruiting molecules for the treatment of coronavirus disease-19. The present disclosure... |
|
|
Invention
|
Bifunctional small molecules to target the selective degradation of circulating proteins. The pre... |
|
|
Invention
|
Antibody-drug conjugates for delivering cytotoxic agents. Provided is a compound having the struc... |
|
|
Invention
|
Administration of fibronectin based scaffold domain proteins to treat overweight, obesity, and re... |
|
|
Invention
|
Treatment of neurodegenerative disorders with doxycycline alone or in combination with levodopa. ... |
|
|
Invention
|
Bifunctional molecules to target degradation of interleukin 17a (il-17a). The present disclosure ... |
|
|
Invention
|
Bifunctional molecules to target degradation of tumor necrosis factor. The present disclosure des... |
|
2023
|
G/S
|
Pharmaceutical products, namely, modified antibodies and modified derivatives of antibodies that ... |
|
|
G/S
|
Pharmaceutical products, namely, multifunctional molecules that bind to extracellular circulating... |
|
|
G/S
|
Pharmaceutical products, namely, multifunctional molecules
that bind to extracellular circulatin... |
|
|
G/S
|
Pharmaceutical products, namely, modified antibodies and
modified derivatives of antibodies that... |
|
|
G/S
|
Pharmaceutical products for use in the treatment of neurological and neuropsychiatric diseases an... |
|
|
G/S
|
Pharmaceutical products for use in the treatment of
neurological and neuropsychiatric diseases a... |
|
|
Invention
|
Combination therapies including metal channel activators. Provided is a pharmaceutical compositio... |
|
|
Invention
|
Combination therapies including metal channel activators and tdp-43 modulators. Provided is a pha... |
|
|
Invention
|
Combination therapies including metal channel activators and nmda receptor antagonists. Provided ... |
|
|
G/S
|
Discovery, research, development, engineering, and testing of pharmaceuticals and substances, nam... |
|
|
G/S
|
Pharmaceutical products, namely, multifunctional molecules that promote recruitment of antibodies... |
|
|
G/S
|
Pharmaceutical research, development, discovery, testing, and collaboration for others, in the ar... |
|
|
G/S
|
Printed publications in the nature of brochures, pamphlets, and written articles for medical info... |
|
|
G/S
|
Medicated and pharmaceutical preparations, both prescription and over-the-counter, for the treatm... |
|
|
Invention
|
Methods of treating glioblastoma with prodrugs of riluzole. Provided is a method of treating glio... |
|
|
Invention
|
Indazole derivatives for treating trpm3-mediated disorders. The invention relates to compounds th... |
|
|
Invention
|
Pyrazolo[1,5-a]pyridine derivatives for treating trpm3-mediated disorders. The invention relates ... |
|
|
Invention
|
Indolizine derivatives for treating trpm3-mediated disorders. The invention relates to compounds ... |
|
|
Invention
|
New derivatives for treating trpm3 mediated disorders. The invention relates to compounds that ar... |
|
|
Invention
|
Methods of treating spinocerebellar ataxias. Provided is a method for treating spinocerebellar at... |
|
|
G/S
|
Medicated and pharmaceutical preparations, both prescription
and over-the-counter, for the treat... |
|
|
G/S
|
Medicated and pharmaceutical preparations, both prescription and over-the-counter.. |
|
2022
|
G/S
|
Providing non-downloadable online videos regarding prevention, treatment, diagnosis, and manageme... |
|
2021
|
G/S
|
Pharmaceutical products for use in the treatment of autoimmune disorders, inflammatory diseases a... |
|
|
G/S
|
Medicated pharmaceutical and veterinary preparations, both prescription and over-the-counter, in ... |
|
|
G/S
|
Medicated and pharmaceutical preparations, both prescription
and over-the-counter, for use in co... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of headache, facial pain; Pharmaceutical preparatio... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of headache,
facial pain, impulse control disorder... |
|
|
G/S
|
Medicated, pharmaceutical and veterinary preparations, both prescription and over-the-counter, in... |
